Combined Use of Duloxetine and Olanzapine in the Treatment of Urologic Chronic Pelvic Pain Syndromes Refractory to Conventional Treatment: A Case Report

被引：4

作者：

Bi, Bo ^{[1
]}

Shan, Liping ^{[2
]}

Zhou, Die ^{[1
]}

机构：

[1] China Med Univ, Affiliated Hosp 1, Dept Psychiat, 155 North Nanjing St, Shenyang 110001, Liaoning, Peoples R China

[2] China Med Univ, Shengjing Hosp, Dept Urol, Shenyang, Liaoning, Peoples R China

来源：

CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE | 2018年 / 16卷 / 01期

关键词：

Bladder pain; Painful urinary urgency; Duloxetine; Olanzapine; Anxiety; STRESS URINARY-INCONTINENCE; SEROTONIN; SYMPTOMS; EFFICACY; PLACEBO;

D O I：

10.9758/cpn.2018.16.1.122

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Patients with urologic chronic pelvic pain syndromes (UCPPS) report interstitial cystitis/bladder pain syndrome and/or chronic prostatitis/chronic pelvic pain syndrome. The pathogenesis of these syndromes remains unclear and there is currently no standard treatment. UCPPS is, therefore, often misdiagnosed and its management is complex. The present case report involves a 62-year-old male patient with UCPPS whose main presentation is painful bladder filling and painful urgency refractory to conventional treatment with medication, which was successfully treated with the combined use of duloxetine and olanzapine. The combined use of duloxetine and olanzapine may become a new therapeutic option in the management of UCPPS.

引用

页码：122 / 125

页数：4

共 26 条

[1] Urinary bladder contraction and relaxation: Physiology and pathophysiology [J].